Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates (no-bisphosphonate)
CA 2485090 A1 · Owner: Osteoscreen, Inc. · Inventors: Garrett, I. Ross
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to compositions and methods for use in treating skeletal system disorders in a vertebrate at risk for bone loss and in treating , conditions that are characterized by the need for bone growth in treating , fractures, and in treating cartilage disorders. More specifically the , invention concerns the use of NO-bisphosphonate assembly for enhancing bone growth.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 2, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 2, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 2, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.